HRP20170380T1 - Životinje s humaniziranim il-5 - Google Patents
Životinje s humaniziranim il-5 Download PDFInfo
- Publication number
- HRP20170380T1 HRP20170380T1 HRP20170380TT HRP20170380T HRP20170380T1 HR P20170380 T1 HRP20170380 T1 HR P20170380T1 HR P20170380T T HRP20170380T T HR P20170380TT HR P20170380 T HRP20170380 T HR P20170380T HR P20170380 T1 HRP20170380 T1 HR P20170380T1
- Authority
- HR
- Croatia
- Prior art keywords
- human
- mouse
- exons
- humanized
- protein
- Prior art date
Links
- 241001465754 Metazoa Species 0.000 title 1
- 108090000172 Interleukin-15 Proteins 0.000 claims 35
- 102000003812 Interleukin-15 Human genes 0.000 claims 31
- 108090000623 proteins and genes Proteins 0.000 claims 20
- 108700024394 Exon Proteins 0.000 claims 14
- 101001055166 Mus musculus Interleukin-15 Proteins 0.000 claims 8
- 102000004169 proteins and genes Human genes 0.000 claims 8
- 238000011144 upstream manufacturing Methods 0.000 claims 7
- 238000000034 method Methods 0.000 claims 5
- 101001055157 Homo sapiens Interleukin-15 Proteins 0.000 claims 4
- 241001529936 Murinae Species 0.000 claims 4
- 102000056003 human IL15 Human genes 0.000 claims 4
- 230000001105 regulatory effect Effects 0.000 claims 4
- 108091026890 Coding region Proteins 0.000 claims 3
- 108020004705 Codon Proteins 0.000 claims 3
- 125000003275 alpha amino acid group Chemical group 0.000 claims 3
- 108091036066 Three prime untranslated region Proteins 0.000 claims 2
- 239000012634 fragment Substances 0.000 claims 2
- 108020005345 3' Untranslated Regions Proteins 0.000 claims 1
- 238000006467 substitution reaction Methods 0.000 claims 1
Classifications
-
- A—HUMAN NECESSITIES
- A01—AGRICULTURE; FORESTRY; ANIMAL HUSBANDRY; HUNTING; TRAPPING; FISHING
- A01K—ANIMAL HUSBANDRY; AVICULTURE; APICULTURE; PISCICULTURE; FISHING; REARING OR BREEDING ANIMALS, NOT OTHERWISE PROVIDED FOR; NEW BREEDS OF ANIMALS
- A01K67/00—Rearing or breeding animals, not otherwise provided for; New or modified breeds of animals
- A01K67/027—New or modified breeds of vertebrates
- A01K67/0275—Genetically modified vertebrates, e.g. transgenic
- A01K67/0278—Knock-in vertebrates, e.g. humanised vertebrates
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07K—PEPTIDES
- C07K14/00—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
- C07K14/435—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans
- C07K14/52—Cytokines; Lymphokines; Interferons
- C07K14/54—Interleukins [IL]
- C07K14/5443—IL-15
-
- C—CHEMISTRY; METALLURGY
- C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
- C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
- C12N15/00—Mutation or genetic engineering; DNA or RNA concerning genetic engineering, vectors, e.g. plasmids, or their isolation, preparation or purification; Use of hosts therefor
- C12N15/09—Recombinant DNA-technology
- C12N15/63—Introduction of foreign genetic material using vectors; Vectors; Use of hosts therefor; Regulation of expression
- C12N15/79—Vectors or expression systems specially adapted for eukaryotic hosts
- C12N15/85—Vectors or expression systems specially adapted for eukaryotic hosts for animal cells
- C12N15/8509—Vectors or expression systems specially adapted for eukaryotic hosts for animal cells for producing genetically modified animals, e.g. transgenic
-
- A—HUMAN NECESSITIES
- A01—AGRICULTURE; FORESTRY; ANIMAL HUSBANDRY; HUNTING; TRAPPING; FISHING
- A01K—ANIMAL HUSBANDRY; AVICULTURE; APICULTURE; PISCICULTURE; FISHING; REARING OR BREEDING ANIMALS, NOT OTHERWISE PROVIDED FOR; NEW BREEDS OF ANIMALS
- A01K2207/00—Modified animals
- A01K2207/15—Humanized animals
-
- A—HUMAN NECESSITIES
- A01—AGRICULTURE; FORESTRY; ANIMAL HUSBANDRY; HUNTING; TRAPPING; FISHING
- A01K—ANIMAL HUSBANDRY; AVICULTURE; APICULTURE; PISCICULTURE; FISHING; REARING OR BREEDING ANIMALS, NOT OTHERWISE PROVIDED FOR; NEW BREEDS OF ANIMALS
- A01K2217/00—Genetically modified animals
- A01K2217/07—Animals genetically altered by homologous recombination
-
- A—HUMAN NECESSITIES
- A01—AGRICULTURE; FORESTRY; ANIMAL HUSBANDRY; HUNTING; TRAPPING; FISHING
- A01K—ANIMAL HUSBANDRY; AVICULTURE; APICULTURE; PISCICULTURE; FISHING; REARING OR BREEDING ANIMALS, NOT OTHERWISE PROVIDED FOR; NEW BREEDS OF ANIMALS
- A01K2217/00—Genetically modified animals
- A01K2217/07—Animals genetically altered by homologous recombination
- A01K2217/072—Animals genetically altered by homologous recombination maintaining or altering function, i.e. knock in
-
- A—HUMAN NECESSITIES
- A01—AGRICULTURE; FORESTRY; ANIMAL HUSBANDRY; HUNTING; TRAPPING; FISHING
- A01K—ANIMAL HUSBANDRY; AVICULTURE; APICULTURE; PISCICULTURE; FISHING; REARING OR BREEDING ANIMALS, NOT OTHERWISE PROVIDED FOR; NEW BREEDS OF ANIMALS
- A01K2227/00—Animals characterised by species
- A01K2227/10—Mammal
-
- A—HUMAN NECESSITIES
- A01—AGRICULTURE; FORESTRY; ANIMAL HUSBANDRY; HUNTING; TRAPPING; FISHING
- A01K—ANIMAL HUSBANDRY; AVICULTURE; APICULTURE; PISCICULTURE; FISHING; REARING OR BREEDING ANIMALS, NOT OTHERWISE PROVIDED FOR; NEW BREEDS OF ANIMALS
- A01K2227/00—Animals characterised by species
- A01K2227/10—Mammal
- A01K2227/105—Murine
-
- A—HUMAN NECESSITIES
- A01—AGRICULTURE; FORESTRY; ANIMAL HUSBANDRY; HUNTING; TRAPPING; FISHING
- A01K—ANIMAL HUSBANDRY; AVICULTURE; APICULTURE; PISCICULTURE; FISHING; REARING OR BREEDING ANIMALS, NOT OTHERWISE PROVIDED FOR; NEW BREEDS OF ANIMALS
- A01K2267/00—Animals characterised by purpose
- A01K2267/03—Animal model, e.g. for test or diseases
-
- A—HUMAN NECESSITIES
- A01—AGRICULTURE; FORESTRY; ANIMAL HUSBANDRY; HUNTING; TRAPPING; FISHING
- A01K—ANIMAL HUSBANDRY; AVICULTURE; APICULTURE; PISCICULTURE; FISHING; REARING OR BREEDING ANIMALS, NOT OTHERWISE PROVIDED FOR; NEW BREEDS OF ANIMALS
- A01K2267/00—Animals characterised by purpose
- A01K2267/03—Animal model, e.g. for test or diseases
- A01K2267/035—Animal model for multifactorial diseases
- A01K2267/0387—Animal model for diseases of the immune system
-
- C—CHEMISTRY; METALLURGY
- C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
- C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
- C12N15/00—Mutation or genetic engineering; DNA or RNA concerning genetic engineering, vectors, e.g. plasmids, or their isolation, preparation or purification; Use of hosts therefor
- C12N15/09—Recombinant DNA-technology
- C12N15/63—Introduction of foreign genetic material using vectors; Vectors; Use of hosts therefor; Regulation of expression
- C12N15/79—Vectors or expression systems specially adapted for eukaryotic hosts
- C12N15/85—Vectors or expression systems specially adapted for eukaryotic hosts for animal cells
- C12N15/8509—Vectors or expression systems specially adapted for eukaryotic hosts for animal cells for producing genetically modified animals, e.g. transgenic
- C12N2015/8527—Vectors or expression systems specially adapted for eukaryotic hosts for animal cells for producing genetically modified animals, e.g. transgenic for producing animal models, e.g. for tests or diseases
Landscapes
- Life Sciences & Earth Sciences (AREA)
- Health & Medical Sciences (AREA)
- Chemical & Material Sciences (AREA)
- Genetics & Genomics (AREA)
- Zoology (AREA)
- Organic Chemistry (AREA)
- Engineering & Computer Science (AREA)
- General Health & Medical Sciences (AREA)
- Biotechnology (AREA)
- Environmental Sciences (AREA)
- Veterinary Medicine (AREA)
- Biochemistry (AREA)
- Molecular Biology (AREA)
- Biophysics (AREA)
- Wood Science & Technology (AREA)
- Bioinformatics & Cheminformatics (AREA)
- General Engineering & Computer Science (AREA)
- Biomedical Technology (AREA)
- Biodiversity & Conservation Biology (AREA)
- Animal Husbandry (AREA)
- Animal Behavior & Ethology (AREA)
- Medicinal Chemistry (AREA)
- Proteomics, Peptides & Aminoacids (AREA)
- Toxicology (AREA)
- Gastroenterology & Hepatology (AREA)
- Microbiology (AREA)
- Physics & Mathematics (AREA)
- Plant Pathology (AREA)
- Micro-Organisms Or Cultivation Processes Thereof (AREA)
- Peptides Or Proteins (AREA)
- Preparation Of Compounds By Using Micro-Organisms (AREA)
- Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
- Medicines Containing Material From Animals Or Micro-Organisms (AREA)
Claims (12)
1. Genetički modificirani miš, naznačen time što mu genom sadrži zamjenu u endogenom mišjem lokusu IL-15, u mišjem genomskom fragmentu koji kodira zreli mišji polipeptid IL-15, ljudskim genomskim segmentom koji kodira zreli ljudski polipeptid IL-15, gdje ljudske egzone u IL-15 u navedenom ljudskom genomskom segmentu čine ljudski egzoni 3, 4, 5 i 6 koji kodiraju protein IL-15, kako bi se dobilo humanizirani gen za IL-15, gdje su egzoni u IL-15 tako obrojčani da je prvi kodirajući egzon egzon 1, te gdje je humanizirani gen za IL-15 pod kontrolom svih endogenih mišjih uzvodnih regulacijskih elemenata za IL-15 na endogenom mišjem lokusu IL-15.
2. Genetički modificirani miš u skladu s patentnim zahtjevom 1, naznačen time što humanizirani gen koji kodira IL-15 kodira protein koji sadrži aminokiselinski slijed sa SEQ ID NO: 5.
3. Genetički modificirani miš u skladu s patentnim zahtjevom 1, naznačen time što ljudski genomski segment dodatno sadrži slijed ljudskog introna uzvodno od naj-5′-smještenog ljudskog egzona i ljudski slijed koji ne kodira protein nizvodno od ljudskog stop kodona i nizvodno od ljudskog 3′ UTR.
4. Postupak dobivanja gentički modificiranog miša, naznačen time što se sastoji u modificiranju mišjeg genoma zamjenom mišjeg genomskog fragmenta koji kodira zreli mišji polipeptid IL-15 na endogenom mišjem lokusu IL-15 ljudskim genomskim segmentom koji kodira zreli ljudski polipeptid IL-15, gdje ljudske egzone u IL-15 u navedenom ljudskom genomskom segmentu čine ljudski egzoni 3, 4, 5 i 6 koji kodiraju protein IL-15, kako bi se dobilo humanizirani gen za IL-15, gdje su egzoni u IL-15 tako obrojčani da je prvi kodirajući egzon egzon 1, te gdje je humanizirani gen za IL-15 pod kontrolom svih endogenih mišjih uzvodnih regulacijskih elemenata za IL-15 na endogenom mišjem lokusu IL-15.
5. Postupak u skladu s patentnim zahtjevom 4, naznačen time što ljudski genomski segment dodatno sadrži slijed ljudskog introna uzvodno od naj-5′-smještenog ljudskog egzona i ljudski slijed koji ne kodira protein nizvodno od ljudskog stop kodona i nizvodno od ljudskog 3′ UTR.
6. Postupak u skladu s patentnim zahtjevom 4, naznačen time što humanizirani gen koji kodira IL-15 kodira protein koji sadrži aminokiselinski slijed sa SEQ ID NO: 5.
7. Genetički modificirani miš, naznačen time što mu genom sadrži humanizirani gen za IL-15, gdje navedeni humanizirani gen za IL-15 sadrži mišje egzone 1 i 2 koji kodiraju protein IL-15 i ljudski genomski segment, gdje ljudske egzone u IL-15 u navedenom ljudskom genomskom segmentu čine ljudski egzoni 3, 4, 5 i 6 koji kodiraju protein IL-15, gdje su egzoni u IL-15 tako obrojčani da je prvi kodirajući egzon egzon 1, gdje je humanizirani gen za IL-15 pod kontrolom svih mišjih regulacijskih elemenata za IL-15 uzvodno od endogenog mišjeg lokusa IL-15, te gdje navedeni humanizirani gen za IL-15 kodira protein koji sadrži slijed zrelog ljudskog polipeptida IL-15.
8. Genetički modificirani miš u skladu s patentnim zahtjevom 7, naznačen time što humanizirani gen koji kodira IL-15 kodira protein koji sadrži aminokiselinski slijed sa SEQ ID NO: 5.
9. Genetički modificirani miš u skladu s patentnim zahtjevom 7, naznačen time što ljudski genomski segment dodatno sadrži slijed ljudskog introna uzvodno od naj-5′-smještenog ljudskog egzona i ljudski slijed koji ne kodira protein nizvodno od ljudskog stop kodona i nizvodno od ljudskog 3′ UTR.
10. Genetički modificirani miš u skladu s patentnim zahtjevom 7, naznačen time što je humanizirani gen za IL-15 na položaju u mišjem genomu koji nije endogeni lokus IL-15.
11. Postupak dobivanja gentički modificiranog miša, naznačen time što se sastoji u uvođenju u mišji genom humaniziranog gena za IL-15 koji sadrži mišje egzone 1 i 2 koji kodiraju protein IL-15 i ljudski genomski segment, gdje ljudske egzone u IL-15 u navedenom ljudskom genomskom segmentu čine ljudski egzoni 3, 4, 5 i 6 u IL-15, gdje su egzoni u IL-15 tako obrojčani da je prvi kodirajući egzon egzon 1, gdje je humanizirani gen za IL-15 pod kontrolom svih mišjih regulacijskih elemenata za IL-15 uzvodno od endogenog mišjeg lokusa IL-15, te gdje navedeni humanizirani gen za IL-15 kodira protein koji sadrži slijed zrelog ljudskog polipeptida IL-15.
12. Postupak u skladu s patentnim zahtjevom 11, naznačen time što je humanizirani gen za IL-15 integriran u genom na položaju koji nije endogeni lokus IL-15.
Applications Claiming Priority (3)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| US201361891013P | 2013-10-15 | 2013-10-15 | |
| EP14790452.8A EP2908626B1 (en) | 2013-10-15 | 2014-10-15 | Humanized il-15 animals |
| PCT/US2014/060568 WO2015057758A1 (en) | 2013-10-15 | 2014-10-15 | Humanized il-15 animals |
Publications (1)
| Publication Number | Publication Date |
|---|---|
| HRP20170380T1 true HRP20170380T1 (hr) | 2017-05-19 |
Family
ID=51830649
Family Applications (2)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| HRP20170380TT HRP20170380T1 (hr) | 2013-10-15 | 2017-03-07 | Životinje s humaniziranim il-5 |
| HRP20190542TT HRP20190542T1 (hr) | 2013-10-15 | 2019-03-20 | Životinje s humaniziranim il-15 |
Family Applications After (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| HRP20190542TT HRP20190542T1 (hr) | 2013-10-15 | 2019-03-20 | Životinje s humaniziranim il-15 |
Country Status (28)
| Country | Link |
|---|---|
| US (5) | US9155290B2 (hr) |
| EP (3) | EP3138397B1 (hr) |
| JP (3) | JP6492095B2 (hr) |
| KR (1) | KR102376041B1 (hr) |
| CN (2) | CN105744829B (hr) |
| AU (2) | AU2014337526B2 (hr) |
| BR (1) | BR112016008175A2 (hr) |
| CA (1) | CA2926090C (hr) |
| CY (2) | CY1118675T1 (hr) |
| DK (2) | DK3138397T3 (hr) |
| ES (2) | ES2613379T3 (hr) |
| HK (1) | HK1210659A1 (hr) |
| HR (2) | HRP20170380T1 (hr) |
| HU (2) | HUE033272T2 (hr) |
| IL (2) | IL244525B (hr) |
| LT (2) | LT3138397T (hr) |
| MX (1) | MX2016004781A (hr) |
| NZ (1) | NZ718655A (hr) |
| PL (2) | PL3138397T3 (hr) |
| PT (2) | PT2908626T (hr) |
| RS (2) | RS58465B1 (hr) |
| RU (1) | RU2674910C2 (hr) |
| SG (2) | SG10201607768YA (hr) |
| SI (2) | SI3138397T1 (hr) |
| SM (1) | SMT201700024B (hr) |
| TR (1) | TR201904342T4 (hr) |
| WO (1) | WO2015057758A1 (hr) |
| ZA (1) | ZA201601676B (hr) |
Families Citing this family (44)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| ES2700852T3 (es) | 2009-10-06 | 2019-02-19 | Regeneron Pharma | Ratones modificados genéticamente e injerto |
| SG10202008003VA (en) | 2011-02-15 | 2020-10-29 | Regeneron Pharma | Humanized m-csf mice |
| JP6283031B2 (ja) | 2012-09-07 | 2018-02-21 | イエール ユニバーシティ | 遺伝学的に修飾された非ヒト動物およびその使用法 |
| CN114766432A (zh) | 2012-11-05 | 2022-07-22 | 再生元制药公司 | 经遗传修饰的非人动物及其使用方法 |
| RS58465B1 (sr) | 2013-10-15 | 2019-04-30 | Regeneron Pharma | Humanizovane il-15 životinje |
| MX2016014504A (es) | 2014-05-05 | 2017-05-23 | Regeneron Pharma | Animales c5 y c3 humanizados. |
| NO2785538T3 (hr) | 2014-05-07 | 2018-08-04 | ||
| KR20240017405A (ko) | 2014-05-19 | 2024-02-07 | 리제너론 파마슈티칼스 인코포레이티드 | 인간 epo를 발현하는 유전자 변형된 비-인간 동물 |
| MX2017007293A (es) | 2014-12-05 | 2018-03-12 | Regeneron Pharma | Animales no humanos que tienen un gen del grupo de diferenciacion 47 humanizado. |
| CN115943929A (zh) | 2015-04-13 | 2023-04-11 | 再生元制药公司 | 人源化SIRPα-IL15敲入小鼠及其使用方法 |
| JP6843872B2 (ja) | 2016-02-04 | 2021-03-17 | リジェネロン・ファーマシューティカルズ・インコーポレイテッドＲｅｇｅｎｅｒｏｎ Ｐｈａｒｍａｃｅｕｔｉｃａｌｓ， Ｉｎｃ． | 操作されたａｎｇｐｔｌ８遺伝子を有する非ヒト動物 |
| SG10202001578RA (en) | 2016-02-29 | 2020-04-29 | Regeneron Pharma | Rodents having a humanized tmprss gene |
| EP3476865B1 (en) | 2016-06-28 | 2023-09-13 | Biocytogen Pharmaceuticals (Beijing) Co., Ltd. | Method for constructing pd-1 gene-modified humanized animal model and use thereof |
| CN107815467B (zh) | 2016-08-31 | 2021-03-16 | 百奥赛图(北京)医药科技股份有限公司 | 人源化基因改造动物模型的制备方法及应用 |
| CN107815468B (zh) | 2016-08-31 | 2021-03-16 | 百奥赛图(北京)医药科技股份有限公司 | 人源化基因改造动物模型的制备方法及应用 |
| WO2018041121A1 (en) | 2016-08-31 | 2018-03-08 | Beijing Biocytogen Co., Ltd | Genetically modified non-human animal with human or chimeric ctla-4 |
| WO2018041118A1 (en) | 2016-08-31 | 2018-03-08 | Beijing Biocytogen Co., Ltd | Genetically modified non-human animal with human or chimeric pd-l1 |
| WO2018041120A1 (en) | 2016-08-31 | 2018-03-08 | Beijing Biocytogen Co., Ltd | Genetically modified non-human animal with human or chimeric tigit |
| WO2018086594A1 (en) | 2016-11-11 | 2018-05-17 | Beijing Biocytogen Co., Ltd | Genetically modified non-human animal with human or chimeric tim-3 |
| CN108070613B (zh) | 2016-11-11 | 2020-03-13 | 百奥赛图江苏基因生物技术有限公司 | 人源化基因改造动物模型的制备方法及应用 |
| CN108239659B (zh) | 2016-12-23 | 2020-03-03 | 百奥赛图江苏基因生物技术有限公司 | 人源化基因改造动物模型的制备方法及应用 |
| CN108424928B (zh) | 2016-12-30 | 2021-03-16 | 百奥赛图(北京)医药科技股份有限公司 | 人源化基因改造动物模型的制备方法及应用 |
| CN108467873B (zh) | 2017-03-17 | 2020-03-13 | 百奥赛图江苏基因生物技术有限公司 | 一种cd132基因缺失的免疫缺陷动物模型的制备方法及应用 |
| WO2018177441A1 (en) | 2017-03-31 | 2018-10-04 | Beijing Biocytogen Co., Ltd | GENETICALLY MODIFIED NON-HUMAN ANIMAL WITH HUMAN OR CHIMERIC SIRPα |
| CN108588126B (zh) | 2017-03-31 | 2020-04-10 | 北京百奥赛图基因生物技术有限公司 | Cd47基因人源化改造动物模型的制备方法及应用 |
| CN109136275B (zh) | 2017-06-19 | 2021-03-16 | 百奥赛图(北京)医药科技股份有限公司 | 人源化gitr基因改造动物模型的制备方法及应用 |
| CN109136274B (zh) | 2017-06-19 | 2021-04-23 | 百奥赛图江苏基因生物技术有限公司 | 人源化cd40基因改造动物模型的制备方法及应用 |
| CN109136261B (zh) | 2017-06-19 | 2021-03-16 | 百奥赛图(北京)医药科技股份有限公司 | 人源化cd28基因改造动物模型的制备方法及应用 |
| JP7404237B2 (ja) * | 2017-08-09 | 2023-12-25 | ザ ジャクソン ラボラトリー | ヒトインターロイキン１５を発現する免疫不全マウス |
| US20190098879A1 (en) | 2017-09-29 | 2019-04-04 | Regeneron Pharmaceuticals, Inc. | Non-Human Animals Comprising A Humanized TTR Locus And Methods Of Use |
| WO2019072241A1 (en) | 2017-10-13 | 2019-04-18 | Beijing Biocytogen Co., Ltd | NON-HUMAN ANIMAL GENETICALLY MODIFIED WITH PD-1 HUMAN OR CHIMERIC |
| WO2019114768A1 (en) | 2017-12-12 | 2019-06-20 | Biocytogen Jiangsu Co., Ltd. | GENETICALLY MODIFIED NON-HUMAN ANIMAL WITH HUMAN OR CHIMERIC CD3e |
| CA3098040A1 (en) | 2018-07-16 | 2020-01-23 | Regeneron Pharmaceuticals, Inc. | Non-human animal models of ditra disease and uses thereof |
| WO2020074005A1 (en) | 2018-10-12 | 2020-04-16 | Beijing Biocytogen Co., Ltd | Genetically modified non-human animal with human or chimeric genes |
| WO2020125763A1 (en) | 2018-12-20 | 2020-06-25 | Biocytogen Jiangsu Co., Ltd. | Genetically modified non-human animal with human or chimeric lag3 |
| CN111304248B (zh) * | 2018-12-25 | 2021-08-24 | 百奥赛图江苏基因生物技术有限公司 | 人源化细胞因子il15基因改造非人动物的构建方法及应用 |
| CN111218425B (zh) * | 2019-01-17 | 2022-02-08 | 百奥赛图(北京)医药科技股份有限公司 | 人源化转基因动物 |
| US11737435B2 (en) | 2019-04-04 | 2023-08-29 | Regeneron Pharmaceuticals, Inc. | Non-human animals comprising a humanized coagulation factor 12 locus |
| JP2022534867A (ja) | 2019-06-04 | 2022-08-04 | リジェネロン・ファーマシューティカルズ・インコーポレイテッド | ベータスリップ変異を有するヒト化ｔｔｒ遺伝子座を含む非ヒト動物と使用方法 |
| AU2020289581A1 (en) | 2019-06-07 | 2021-11-18 | Regeneron Pharmaceuticals, Inc. | Non-human animals comprising a humanized albumin locus |
| CN114786479B (zh) * | 2019-12-25 | 2023-12-15 | 江苏集萃药康生物科技股份有限公司 | 一种il-15人源化小鼠模型及其用途 |
| WO2021154791A1 (en) * | 2020-01-28 | 2021-08-05 | Regeneron Pharmaceuticals, Inc. | Non-human animals comprising a humanized pnpla3 locus and methods of use |
| CN111485001A (zh) * | 2020-04-14 | 2020-08-04 | 澎立生物医药技术（上海）有限公司 | 具有nk细胞及adcc能力的人源化免疫系统小鼠的构建方法 |
| CN112481303B (zh) * | 2021-02-09 | 2021-05-25 | 百奥赛图(北京)医药科技股份有限公司 | Il15ra基因人源化非人动物及其构建方法和应用 |
Family Cites Families (18)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| AU2001239750A1 (en) | 2000-02-08 | 2001-08-20 | Genaissance Pharmaceuticals, Inc. | Haplotypes of the interleukin 15 gene |
| US7759541B2 (en) * | 2004-12-13 | 2010-07-20 | Iti Life Sciences | Transgenic animals for assessing drug metabolism and toxicity |
| NZ581779A (en) * | 2005-05-17 | 2011-09-30 | Univ Connecticut | Composition and methods for immunomodulation in an organism comprising interleukin-15 polypeptide and interleukin-15 receptor subunit A polypeptide complex |
| CA2729095C (en) * | 2008-06-27 | 2018-12-04 | Merus B.V. | Method for producing a transgenic murine mammal |
| RU2425880C2 (ru) * | 2009-07-30 | 2011-08-10 | Учреждение Российской академии наук Институт общей генетики им. Н.И. Вавилова РАН | Способ получения трансгенных мышей |
| ES2700852T3 (es) | 2009-10-06 | 2019-02-19 | Regeneron Pharma | Ratones modificados genéticamente e injerto |
| SG10201408415PA (en) * | 2009-12-21 | 2015-01-29 | Regeneron Pharma | HUMANIZED FCγ R MICE |
| SG10202008003VA (en) * | 2011-02-15 | 2020-10-29 | Regeneron Pharma | Humanized m-csf mice |
| US9043996B2 (en) * | 2011-10-28 | 2015-06-02 | Regeneron Pharmaceuticals, Inc. | Genetically modified major histocompatibility complex animals |
| LT3262932T (lt) | 2011-10-28 | 2019-08-26 | Regeneron Pharmaceuticals, Inc. | Pelės su genetiškai modifikuotu pagrindiniu histosuderinamumo kompleksu |
| RS53683B1 (en) * | 2011-10-28 | 2015-04-30 | Regeneron Pharmaceuticals Inc. | HUMANIZOVANI IL-6 I IL-6 RECEPTOR |
| RU2660564C2 (ru) * | 2011-10-28 | 2018-07-06 | Регенерон Фармасьютикалз, Инк. | Генетически модифицированные мыши, экспрессирующие химерные молекулы главного комплекса гистосовместимости |
| US8962913B2 (en) | 2012-06-18 | 2015-02-24 | Regeneron Pharmaceuticals, Inc. | Humanized IL-7 rodents |
| JP6283031B2 (ja) | 2012-09-07 | 2018-02-21 | イエール ユニバーシティ | 遺伝学的に修飾された非ヒト動物およびその使用法 |
| CN114766432A (zh) | 2012-11-05 | 2022-07-22 | 再生元制药公司 | 经遗传修饰的非人动物及其使用方法 |
| LT2958937T (lt) | 2013-02-22 | 2018-11-26 | Regeneron Pharmaceuticals, Inc. | Pelė, ekspresuojanti humanizuotą audinių dermės kompleksą |
| DK3175706T3 (en) | 2013-09-23 | 2019-03-04 | Regeneron Pharma | Non-human animals with a humanized signal regulatory protein gene |
| RS58465B1 (sr) | 2013-10-15 | 2019-04-30 | Regeneron Pharma | Humanizovane il-15 životinje |
-
2014
- 2014-10-15 RS RS20190349A patent/RS58465B1/sr unknown
- 2014-10-15 RU RU2016116847A patent/RU2674910C2/ru active
- 2014-10-15 AU AU2014337526A patent/AU2014337526B2/en active Active
- 2014-10-15 SG SG10201607768YA patent/SG10201607768YA/en unknown
- 2014-10-15 JP JP2016549191A patent/JP6492095B2/ja active Active
- 2014-10-15 PL PL16192440T patent/PL3138397T3/pl unknown
- 2014-10-15 US US14/514,454 patent/US9155290B2/en active Active
- 2014-10-15 EP EP16192440.2A patent/EP3138397B1/en active Active
- 2014-10-15 CN CN201480056455.3A patent/CN105744829B/zh active Active
- 2014-10-15 LT LTEP16192440.2T patent/LT3138397T/lt unknown
- 2014-10-15 EP EP14790452.8A patent/EP2908626B1/en active Active
- 2014-10-15 PT PT147904528T patent/PT2908626T/pt unknown
- 2014-10-15 WO PCT/US2014/060568 patent/WO2015057758A1/en active Application Filing
- 2014-10-15 TR TR2019/04342T patent/TR201904342T4/tr unknown
- 2014-10-15 DK DK16192440.2T patent/DK3138397T3/en active
- 2014-10-15 SI SI201431130T patent/SI3138397T1/sl unknown
- 2014-10-15 LT LTEP14790452.8T patent/LT2908626T/lt unknown
- 2014-10-15 PL PL14790452T patent/PL2908626T3/pl unknown
- 2014-10-15 ES ES14790452.8T patent/ES2613379T3/es active Active
- 2014-10-15 SG SG11201601828XA patent/SG11201601828XA/en unknown
- 2014-10-15 RS RS20161140A patent/RS55472B1/sr unknown
- 2014-10-15 NZ NZ718655A patent/NZ718655A/en unknown
- 2014-10-15 HU HUE14790452A patent/HUE033272T2/en unknown
- 2014-10-15 ES ES16192440T patent/ES2715949T3/es active Active
- 2014-10-15 CN CN201810808707.3A patent/CN109090037B/zh active Active
- 2014-10-15 KR KR1020167009228A patent/KR102376041B1/ko active IP Right Grant
- 2014-10-15 BR BR112016008175A patent/BR112016008175A2/pt not_active Application Discontinuation
- 2014-10-15 PT PT16192440T patent/PT3138397T/pt unknown
- 2014-10-15 EP EP18206034.3A patent/EP3461331A1/en not_active Withdrawn
- 2014-10-15 CA CA2926090A patent/CA2926090C/en active Active
- 2014-10-15 DK DK14790452.8T patent/DK2908626T3/en active
- 2014-10-15 MX MX2016004781A patent/MX2016004781A/es unknown
- 2014-10-15 SI SI201430109T patent/SI2908626T1/sl unknown
- 2014-10-15 HU HUE16192440A patent/HUE043969T2/hu unknown
-
2015
- 2015-09-01 US US14/842,342 patent/US20150366175A1/en not_active Abandoned
- 2015-11-20 HK HK15111500.3A patent/HK1210659A1/xx unknown
-
2016
- 2016-03-10 IL IL24452516A patent/IL244525B/en active IP Right Grant
- 2016-03-10 ZA ZA2016/01676A patent/ZA201601676B/en unknown
-
2017
- 2017-01-04 CY CY20171100008T patent/CY1118675T1/el unknown
- 2017-01-16 SM SM201700024T patent/SMT201700024B/it unknown
- 2017-03-07 HR HRP20170380TT patent/HRP20170380T1/hr unknown
- 2017-12-06 US US15/832,976 patent/US10561125B2/en active Active
-
2018
- 2018-10-16 JP JP2018194898A patent/JP6600061B2/ja active Active
-
2019
- 2019-03-18 CY CY20191100323T patent/CY1121405T1/el unknown
- 2019-03-20 HR HRP20190542TT patent/HRP20190542T1/hr unknown
- 2019-10-03 JP JP2019182817A patent/JP2019216750A/ja active Pending
- 2019-10-10 IL IL269907A patent/IL269907B/en active IP Right Grant
-
2020
- 2020-01-02 US US16/732,400 patent/US11503813B2/en active Active
- 2020-12-08 AU AU2020286186A patent/AU2020286186B2/en active Active
-
2022
- 2022-10-17 US US18/047,014 patent/US20230189772A1/en active Pending
Also Published As
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| HRP20170380T1 (hr) | Životinje s humaniziranim il-5 | |
| JP2019022518A5 (hr) | ||
| RU2014148107A (ru) | Грызуны с гуманизированным il-7 | |
| RU2016123135A (ru) | Отличные от человека животные, содержащие гуманизированный ген индуцирующего пролиферацию лиганда | |
| HRP20210662T1 (hr) | Neljudske životinje koje imaju humanizirani gen za diferencijacijski biljeg 47 | |
| RU2017129763A (ru) | Гуманизированные il-6 и рецептор il-6 | |
| JP2010516235A5 (hr) | ||
| RU2016143036A (ru) | Не относящиеся к человеку животные, имеющие гуманизированные fc-гамма-рецепторы | |
| NZ712508A (en) | Non-human animals expressing ph-sensitive immunoglobulin sequences | |
| SI3027015T1 (en) | HUMANIZED IL-4 AND IL-4R ALPHA ANIMALS | |
| JP2013544090A5 (hr) | ||
| WO2013092743A3 (en) | Expression vector element combinations, novel production cell generation methods and their use for the recombinant production of polypeptides | |
| BR112014015705A8 (pt) | polipeptídeo isolado, composição, polinucleotídeo isolado,, construção de ácido nucleico ou vetor de expressão, célula hospedeira, métodos para produzir um polipeptídeo, para melhorar o valor nutritivo de uma ração parar animais e para o tratamento de proteínas, planta transgênica, parte de planta ou célula vegetal, uso de pelo menos um polipeptídeo, aditivo de ração para animal, ração para animais, e, composição detergente | |
| EA201490958A8 (ru) | Засухоустойчивые растения, полученные путем модификации генного локуса stgx, ответственного за фенотип оставаться зеленым | |
| RU2016105639A (ru) | Гены, обеспечивающие устойчивость подсолнечника к ложной мучнистой росе | |
| RU2018146313A (ru) | Грызуны с условными мутантными аллелями acvr1 | |
| MX2019007032A (es) | Operaciones de cosecha mejoradas para proteinas recombinadas. | |
| JP2016506945A5 (hr) | ||
| RU2014129220A (ru) | Новый аттенуированный полиовирус: pv-1 mono-cre-x | |
| JP2016538000A5 (hr) | ||
| PT2459721E (pt) | Sistema de expressão melhorada da pentraxina 3 longa humana e suas utilizações | |
| WO2006110506A3 (en) | Root-specific phoshate transporter promoters | |
| PH12017501858A1 (en) | Plant promoter for transgene expression | |
| RU2011152733A (ru) | Генетические конструкции ltf3, ltf5, ltf7, ltf10, ltf11 для получения рекомбинантного лактоферрина человека (варианты) | |
| Kim et al. | Construction of Knock-in Vector to Produce hEPO Protein using the GST Fusion System on Mouse β-casein Exon 3 locus |